TY - CHAP M1 - Book, Section TI - Urinary Incontinence A1 - Lue, Tom F. A1 - Tanagho, Emil A. A2 - McAninch, Jack W. A2 - Lue, Tom F. PY - 2020 T2 - Smith & Tanagho's General Urology, 19e AB - The worldwide numbers of stress urinary incontinence (SUI) and urgency urinary incontinence (UUI) were projected to affect 167 million (prevalence of 3.3%) and 60 million people (prevalence of 1.21%), respectively by 2018 (Irwin et al, 2011). Urinary incontinence is a major health issue, and the total direct and indirect cost in the United States alone was estimated at $19.5 billion in 2000, of which 75% is designated for the management of women with this condition. Incontinence also results in psychological and medical morbidity, significantly impacting health-related quality of life in a manner similar to other chronic medical conditions including osteoporosis, chronic obstructive pulmonary disease, and stroke. Overall prevalence of female incontinence is reported at 38%, increasing with age from 20–30% during young adult life to almost 50% in the elderly (Anger et al, 2006; Hawkins et al, 2010). The prevalence of stress incontinence peaks in the fifth decade of life, and thereafter the prevalence of mixed and urgency incontinence continues to increase. Several studies conducted in the United States show that stress urinary incontinence is more common in white women than in African-American or Asian-American women (Thom et al, 2006). Advances in the understanding of pathophysiology, as well as development of novel pharmacotherapy and surgical techniques for stress, mixed, and urge incontinence (UI), have redefined contemporary care of this patient group. SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1171184915 ER -